Castle Biosciences Inc (NAS:CSTL)
$ 23.38 -1.1 (-4.49%) Market Cap: 645.46 Mil Enterprise Value: 461.66 Mil PE Ratio: 0 PB Ratio: 1.60 GF Score: 79/100

Castle Biosciences Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 13, 2022 / 06:00PM GMT
Release Date Price: $28.24 (-5.04%)
Tom Peterson
Baird - Analyst

Thanks for joining us here at the Baird healthcare conference. I'm Tom Peterson. I'm associate on our life science tools and diagnostics team here at Baird. We're excited to have Castle Biosciences presenting today. And representing the company, we have CEO Derek Maetzold and CFO Frank Stokes. Derek, Frank, welcome both.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President, & CEO

Thank you. Thank you, Tom. Good to be here.

Tom Peterson
Baird - Analyst

In terms of the agenda, I think, Derek, you're going to launch into a few slides, give a brief company overview, and then we'll get into Q&A.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President, & CEO

Perfect, perfect. Thank you, Tom. Thank you for the Baird team for organizing this event.

Forward-looking statement disclaimer slide. So just a couple slides in the business for those of you who may not have a good handle on Castle. We are a molecular

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot